10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

Chad, Togo and Zambia: updated recommendations for polio vaccination

Circulating vaccine derived poliovirus type 2 has been confirmed by the World Health Organization in these African countries Read more

Polio: Public Health Emergency of International Concern

An update on the polio Public Health Emergency of International Concern (PHEIC) Read more

Ebola Virus Disease (EVD) in Democratic Republic of congo with update to Tanzania

The Ebola virus disease (EVD) outbreak continues in eastern Democratic Republic of Congo (DRC) Read more

Country-specific cholera recommendations 2019

NaTHNaC has updated the country-specific recommendations for cholera Read more

Updated guidelines for malaria prevention in travellers from the UK: 2019

Public Health England (PHE) Advisory Committee on Malaria Prevention (ACMP) has published updated malaria guidelines Read more
Back to Top

VIEW FULL INDEX